CLINICAL HELP
Maryalice Stetler-Stevenson (stetler@box-s.nih.gov)
Fri, 20 Sep 1996 09:43:54 -0400
I am desperate. I have to prepare a report in the next week citing cost of
Flow Cytometric analysis for minimal residual disease at other major
academic centers. If any one out there does complex minimal residual (or
initial) disease type of studies and knowns the cost (including the most
expensive part-tech time in analysis) and would be willing to officially
give me a ball park figure that includes an estimate of the number of
tubes, I would be very grateful. We are talking only bone marrow and
peripheral blood type of specimens, not simple lymph nodes. The number of
tubes we run are, to a degree, determined by protocol demands for
assessment of specific antigens. We therefore can't do a simple comparison
of total MRD determination commparison. You will not be called on to
testify or appear anyplace. It is not for regulatory purposes. This is to
justify my own budget. Thank you in advance for your help.
Maryalice Stetler-Stevenson
Director Flow Cytometry Unit
Laboratory of Pathology, NCI, NIH